1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Gorbatyuk, V.Y. Tsai, C.K. Chang, C.F. Huang, T.H. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US J.Biol.Chem. JBCHA3 0071 0021-9258 279 5772 5780 10.1074/jbc.M311233200 14645226 Effect of N-terminal and Met23 Mutations on the Structure and Dynamics of Onconase 2004 10.2210/pdb1pu3/pdb pdb_00001pu3 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 SINGLE WAVELENGTH M 1 1.0 11975.836 P-30 protein 3.1.27.- M23L 1 man polymer Onconase no no MQDWLTFQKKHITNTRDVDCDNILSTNLFHCKDKNTFIYSRPEPVKAICKGIIASKNVLTTSEFYLSDCNVTSRPCKYKL KKSTNKFCVTCENQAPVHFVGVGSC MQDWLTFQKKHITNTRDVDCDNILSTNLFHCKDKNTFIYSRPEPVKAICKGIIASKNVLTTSEFYLSDCNVTSRPCKYKL KKSTNKFCVTCENQAPVHFVGVGSC A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n northern leopard frog Rana Escherichia Escherichia coli sample 8404 Rana pipiens 469008 Escherichia coli BL21(DE3) BL21(DE3) plasmid pET-11d database_2 pdbx_struct_assembly pdbx_struct_oper_list struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Database references Derived calculations 1 0 2004-03-16 1 1 2008-04-29 1 2 2011-07-13 1 3 2021-10-27 _database_2.pdbx_DOI _database_2.pdbx_database_accession _struct_ref_seq_dif.details 1H,13C,15N chemical shifts assignments of the same protein HNHA coupling constants of the same protein X-ray crystal structure of the native onconase RCSB Y RCSB 2003-06-24 REL REL structures with the lowest energy 100 20 HNHA 3D_15N-separated_NOESY 3D_13C-separated_NOESY 2D TOCSY 2D NOESY 0.3 4.1 ambient 310 K the structures are based on a total of 1802 restraints, 1550 are NOE-derived distance constraints, 4 disulfide bonds, 150 dihedral angle restraints, 98 distance restraints from hydrogen bonds. simulated annealing, matrix relaxation, torsion angle dymanics 1 minimized average structure 1.5 mM (M-1, Q1, M23L)rONC [U-15N; U-13C] 50mM phosphate buffer pH4.1, 90% H2O, 10% D2O Nilges structure solution ARIA 1.2 Brunger structure solution CNS 1.1 Brunger refinement CNS 1.1 600 Bruker DRX MET 1 n 1 MET 1 A GLN 2 n 2 GLN 2 A ASP 3 n 3 ASP 3 A TRP 4 n 4 TRP 4 A LEU 5 n 5 LEU 5 A THR 6 n 6 THR 6 A PHE 7 n 7 PHE 7 A GLN 8 n 8 GLN 8 A LYS 9 n 9 LYS 9 A LYS 10 n 10 LYS 10 A HIS 11 n 11 HIS 11 A ILE 12 n 12 ILE 12 A THR 13 n 13 THR 13 A ASN 14 n 14 ASN 14 A THR 15 n 15 THR 15 A ARG 16 n 16 ARG 16 A ASP 17 n 17 ASP 17 A VAL 18 n 18 VAL 18 A ASP 19 n 19 ASP 19 A CYS 20 n 20 CYS 20 A ASP 21 n 21 ASP 21 A ASN 22 n 22 ASN 22 A ILE 23 n 23 ILE 23 A LEU 24 n 24 LEU 24 A SER 25 n 25 SER 25 A THR 26 n 26 THR 26 A ASN 27 n 27 ASN 27 A LEU 28 n 28 LEU 28 A PHE 29 n 29 PHE 29 A HIS 30 n 30 HIS 30 A CYS 31 n 31 CYS 31 A LYS 32 n 32 LYS 32 A ASP 33 n 33 ASP 33 A LYS 34 n 34 LYS 34 A ASN 35 n 35 ASN 35 A THR 36 n 36 THR 36 A PHE 37 n 37 PHE 37 A ILE 38 n 38 ILE 38 A TYR 39 n 39 TYR 39 A SER 40 n 40 SER 40 A ARG 41 n 41 ARG 41 A PRO 42 n 42 PRO 42 A GLU 43 n 43 GLU 43 A PRO 44 n 44 PRO 44 A VAL 45 n 45 VAL 45 A LYS 46 n 46 LYS 46 A ALA 47 n 47 ALA 47 A ILE 48 n 48 ILE 48 A CYS 49 n 49 CYS 49 A LYS 50 n 50 LYS 50 A GLY 51 n 51 GLY 51 A ILE 52 n 52 ILE 52 A ILE 53 n 53 ILE 53 A ALA 54 n 54 ALA 54 A SER 55 n 55 SER 55 A LYS 56 n 56 LYS 56 A ASN 57 n 57 ASN 57 A VAL 58 n 58 VAL 58 A LEU 59 n 59 LEU 59 A THR 60 n 60 THR 60 A THR 61 n 61 THR 61 A SER 62 n 62 SER 62 A GLU 63 n 63 GLU 63 A PHE 64 n 64 PHE 64 A TYR 65 n 65 TYR 65 A LEU 66 n 66 LEU 66 A SER 67 n 67 SER 67 A ASP 68 n 68 ASP 68 A CYS 69 n 69 CYS 69 A ASN 70 n 70 ASN 70 A VAL 71 n 71 VAL 71 A THR 72 n 72 THR 72 A SER 73 n 73 SER 73 A ARG 74 n 74 ARG 74 A PRO 75 n 75 PRO 75 A CYS 76 n 76 CYS 76 A LYS 77 n 77 LYS 77 A TYR 78 n 78 TYR 78 A LYS 79 n 79 LYS 79 A LEU 80 n 80 LEU 80 A LYS 81 n 81 LYS 81 A LYS 82 n 82 LYS 82 A SER 83 n 83 SER 83 A THR 84 n 84 THR 84 A ASN 85 n 85 ASN 85 A LYS 86 n 86 LYS 86 A PHE 87 n 87 PHE 87 A CYS 88 n 88 CYS 88 A VAL 89 n 89 VAL 89 A THR 90 n 90 THR 90 A CYS 91 n 91 CYS 91 A GLU 92 n 92 GLU 92 A ASN 93 n 93 ASN 93 A GLN 94 n 94 GLN 94 A ALA 95 n 95 ALA 95 A PRO 96 n 96 PRO 96 A VAL 97 n 97 VAL 97 A HIS 98 n 98 HIS 98 A PHE 99 n 99 PHE 99 A VAL 100 n 100 VAL 100 A GLY 101 n 101 GLY 101 A VAL 102 n 102 VAL 102 A GLY 103 n 103 GLY 103 A SER 104 n 104 SER 104 A CYS 105 n 105 CYS 105 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 A N THR 13 A N THR 13 A O ILE 38 A O ILE 38 A N TYR 39 A N TYR 39 A O TYR 65 A O TYR 65 A N ASP 68 A N ASP 68 A O LYS 81 A O LYS 81 A N LYS 56 A N LYS 56 A O CYS 91 A O CYS 91 A N THR 90 A N THR 90 A O HIS 98 A O HIS 98 1 A A OD2 HZ1 ASP LYS 17 82 1.58 2 A A OE1 HZ2 GLU LYS 63 86 1.59 4 A A OE2 HZ1 GLU LYS 63 86 1.59 7 A A HA HD2 ASP TYR 21 78 1.34 8 A A OD1 HG1 ASP THR 3 6 1.60 9 A A O H LYS GLY 86 103 1.59 15 A A HA HH CYS TYR 31 78 1.34 1 A ASN 35 -161.56 115.79 1 A SER 55 -51.81 105.02 1 A THR 72 -89.24 -136.64 1 A VAL 100 -95.54 -65.57 2 A PHE 29 -136.01 -30.13 2 A SER 40 -175.17 148.17 2 A SER 55 -51.44 105.99 2 A THR 72 -93.90 -145.59 3 A ASN 27 -76.74 25.43 3 A PHE 29 -133.98 -36.02 3 A SER 55 -51.56 105.57 3 A THR 72 -114.52 -82.32 3 A SER 73 -94.71 -63.53 3 A VAL 100 -80.13 -79.48 4 A SER 55 -51.93 104.13 4 A THR 72 -97.50 -99.17 4 A VAL 100 -90.64 -72.39 5 A PHE 29 -135.63 -33.91 5 A CYS 31 38.78 62.72 5 A THR 72 -87.26 -140.72 6 A CYS 31 60.19 74.15 6 A SER 55 -51.56 108.61 6 A THR 72 -114.60 -105.48 6 A PRO 96 -59.94 106.40 6 A VAL 100 -79.81 -72.96 7 A ASN 27 -78.50 25.25 7 A ASN 35 -162.41 117.78 7 A SER 55 -51.13 105.95 7 A THR 72 -92.67 -98.31 8 A CYS 31 40.40 79.42 8 A SER 40 -176.59 -177.26 8 A SER 55 -50.29 105.51 8 A THR 72 -114.32 -113.05 9 A GLN 2 64.57 112.76 9 A SER 55 -51.30 106.96 9 A THR 72 -88.89 -152.69 10 A ASP 3 -170.05 -177.72 10 A SER 40 -170.45 -177.50 10 A SER 55 -50.85 102.43 10 A THR 72 -90.69 -106.53 11 A CYS 31 41.26 72.15 11 A SER 55 -50.68 108.60 11 A THR 72 -88.29 -144.54 12 A SER 55 -51.39 109.60 12 A THR 72 -97.67 -133.53 13 A HIS 11 -140.77 -13.79 13 A SER 40 -177.14 -172.36 13 A SER 55 -51.89 106.19 13 A THR 72 -95.58 -142.88 14 A THR 72 -114.36 -108.63 14 A VAL 100 -92.04 -64.82 15 A PHE 29 -130.28 -35.16 15 A CYS 31 48.17 79.74 15 A LYS 32 -77.11 -168.99 15 A SER 55 -48.82 101.07 15 A THR 72 -87.30 -142.37 16 A PHE 29 -133.47 -30.46 16 A CYS 31 61.14 69.72 16 A SER 40 -174.94 147.96 16 A SER 55 -51.27 108.66 16 A THR 72 -88.59 -135.00 17 A SER 40 -177.56 -175.79 17 A SER 55 -50.80 106.53 17 A THR 72 -117.19 -102.07 17 A VAL 100 -102.41 -70.22 18 A GLN 2 68.44 156.90 18 A PHE 29 -132.50 -46.95 18 A SER 55 -53.35 104.36 18 A THR 72 -92.58 -149.29 18 A VAL 100 -85.19 -70.78 19 A PHE 29 -140.88 -30.03 19 A SER 55 -51.69 102.37 19 A THR 72 -104.18 -144.88 19 A VAL 100 -92.82 -72.94 20 A PHE 29 -131.77 -41.90 20 A CYS 31 39.51 73.64 20 A ASN 35 -164.53 114.89 20 A THR 72 -87.72 -146.95 20 A VAL 100 -95.81 -69.15 minimized average The Solution NMR Structure and Dynamics of a Recombinant Onconase with Altered N-terminal and Met23 residues 1 N N A ASP 3 A ASP 3 HELX_P A HIS 11 A HIS 11 1 1 9 A ASP 19 A ASP 19 HELX_P A LEU 24 A LEU 24 1 2 6 A ARG 41 A ARG 41 HELX_P A ALA 47 A ALA 47 1 3 7 A ILE 48 A ILE 48 HELX_P A LYS 50 A LYS 50 5 4 3 disulf 2.028 A CYS 20 A SG CYS 20 1_555 A CYS 69 A SG CYS 69 1_555 disulf 2.033 A CYS 31 A SG CYS 31 1_555 A CYS 76 A SG CYS 76 1_555 disulf 2.022 A CYS 49 A SG CYS 49 1_555 A CYS 91 A SG CYS 91 1_555 disulf 2.027 A CYS 88 A SG CYS 88 1_555 A CYS 105 A SG CYS 105 1_555 HYDROLASE bowl-shaped folding of the two sheets, HYDROLASE RN30_RANPI UNP 1 1 P22069 QDWLTFQKKHITNTRDVDCDNIMSTNLFHCKDKNTFIYSRPEPVKAICKGIIASKNVLTTSEFYLSDCNVTSRPCKYKLK KSTNKFCVTCENQAPVHFVGVGSC 1 104 1PU3 2 105 P22069 A 1 2 105 1 cloning artifact MET 1 1PU3 A P22069 UNP 1 1 MET engineered mutation LEU 24 1PU3 A P22069 UNP 23 24 4 3 parallel anti-parallel anti-parallel anti-parallel anti-parallel A ILE 12 A ILE 12 A THR 13 A THR 13 A LYS 34 A LYS 34 A TYR 39 A TYR 39 A PHE 64 A PHE 64 A VAL 71 A VAL 71 A TYR 78 A TYR 78 A ASN 85 A ASN 85 A LYS 56 A LYS 56 A LEU 59 A LEU 59 A PHE 87 A PHE 87 A GLU 92 A GLU 92 A ALA 95 A ALA 95 A VAL 102 A VAL 102